For the NHS
For business
Solutions
Science
Clinicians
Investors
About Us
Careers
Get in touch
FacebookTwitterLinkedinYouTube

Dr Andy Blackwell

Senior Leadership Team

Andy is ieso’s Chief Science & Strategy Officer. He steers our global science and technology strategy, ensuring it chimes with our commercial vision.

His varied scientific career splits into complementary thirds. In the first, within academia, at the universities of St Andrews and Cambridge, he focussed on how the brain works and how conditions occur. Next, as CSO of Cambridge Cognition, he explored drug-based therapeutics. Finally, as CSO here at ieso, he has investigated how the words exchanged between two people can best treat common mental health conditions. It is this unrivalled breadth of knowledge that makes him uniquely well placed to identify the breakthroughs that will defeat mental illness.

For the next chapter, his eye here at ieso is squarely fixed on digital therapy and the breakthroughs that data science is going to enable.

Andy’s aim has always been to help the largest volume of people. And the software-based digital therapeutics ieso is developing looks set to be even more scalable than the mental telehealth it was instrumental in pioneering.

“I firmly contend that data science is going to tell us more about the brain than all of the biological sciences combined. Physical healthcare benefits from relevant data being readily translated into numbers. The difficulty mental healthcare has faced has been turning language into numbers that can be measured and dosed. By hiring a team of Natural Language Processing data scientists we’re overcoming that challenge at last.

“My first analysis of outcomes at ieso – over a decade ago – revealed a recovery rate of 38%. This same rate is now close to 70% – an industry-leading figure. Our online CBT – done smarter thanks to deep learning insights from our cutting-edge data science team – is now almost twice as effective. That makes me extremely proud and very confident in our ability to produce pivotal breakthroughs.”

Dr Nigel Pitchford

Chief Executive Officer

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Dr Andy Blackwell

Group Chief Science & Strategy Officer

Stephen Freer

EVP Clinical

Dr Charlotte Housden

Chief Operating Officer

Michael Black

Chief Financial Officer

Dani Smallbone

Chief Marketing Officer

Kate Woolland

Chief Partnerships Officer

James Kellerman

Chief Technology Officer

Dr Valentin Tablan

Chief Artificial Intelligence Officer

Dr Jennifer Gentile

SVP US Clinical Operations

Lynn Lakey

Interim Managing Director

Chris Kightley

Interim Managing Director

Dr Andrew Welchman

Executive Vice President for Impact

Danah Tangen

Chief of Staff